Lavo Life Sciences Analysis: $500K Raised
What is Lavo Life Sciences?
Lavo Life Sciences utilizes AI to enhance crystal structure prediction for small molecule drugs, streamlining drug development and reducing risks from unforeseen crystal forms.
Founded
2022
Revenue
$0-0.5M
Company Stage
Seed
YC Batch
W23
Product Features & Capabilities
- AI-powered crystal structure prediction, fast and efficient crystal form identification, risk mitigation for unexpected crystal forms, optimization of drug formulations for stability and manufacturability, discovery of novel polymorphs, acceleration of drug development timelines, enhanced decision-m
How much Lavo Life Sciences raised
1 - $500,000
April 5, 2023Lead Investor: Y Combinator, Eastlink Capital
Who are the founders of Lavo Life Sciences
Investors
- Y Combinator
- Eastlink Capital
- National Science Foundation
- BBQ Capital
- Gershon Capital
